Angioplasty.Org
Most Popular Angioplasty Web Site
   



New Stent Designs      Email Bookmark and Share

Comments about new stent designs, are they better? What's their status? (Also see the separate topic on biodegradable stents.)

Add a Post to This Topic          Return to all Forum Topics

 
Learn About
the Health Benefits
of Sharing Your Story:
Visit Our Patient Community Page

Learn How to Talk to Your Cardiologist:
Visit Our Patient Empowerment Page
The Cardiology Patient Forum needs your help...
Donate Now!

related discussions
in this Forum:

• Biodegradable stents


Click here for more information about these

Current Postings on This Page (4):

• The approval track for these new stents is long -- because of problems with some devices in the past, the FDA has been more stringent on making sure large studies have been done and followed up sufficiently before approving a stent for general use. As for recovery time, that is not something that is sensed by the patient and would have little to do with the "healing" of the arterial wall, but more the patient adjusting to new medications and increased blood flow, etc.
Forum Editor, Angioplasty.Org, July 10, 2009

• My mother-in-law had to have a stent put in a few years ago. The surgery was really rough on her and recovery took longer than the Doctor prepared her to. You stated that this type of stent has a faster healing time, can you detail that (why) please? Also, do you feel this will be made available in the US any time soon? Thank you!
Workemail, Indianapolis, Indiana, June 30, 2009

• Psatha -- the JANUS Optima has the CE mark, but it's not approved in the U.S. or Japan. The stent is stainless-steel, but coated with Carbofilm™ which the company thinks may reduce problems in patients hypersensitive to nickel, and also heal faster. The drug is tacrolimus and, uniquely, there is no polymer which some cardiologists feel is a distinct advantage. However in a disappointing early trial, no differences in results were found between the JANUS Optima and a non-DES carbostent. The chief investigator, Dr. Marie-Claude Morice, feels there may still be promise -- perhaps the drug dosage needs to be higher. This story is not unlike that of the Conor CoStar -- a stent which seemed like a clearly superior idea wound up not performing as well. Cordis bought Conor and is re-launching the CoStar with a different drug and design modification as the NEVO.
Forum Editor, Angioplasty.Org, May 4, 2009

• What about Optima des from Sorin-cid?
Psatha Maria, demo s.a greece, Athens, Greece, May 4, 2009

add your response
Please keep your posting concise. For readability we limit responses to 1,200 characters. Also read our disclaimer at the bottom of the page and note that no information on this Forum should be viewed as a substitute for medical advice or as a consultation with a medical doctor: characters left

Forum name -- how do you want to be identified on your post (Required) your email address (Required):
email address must be current and valid; if email sent to the address
below is returned, your comments will not be posted; your email address
will not be displayed on the Forum unless you specifically request it:
geographic location (city, state, province and/or country -- Required):
REQUIRED -- Check the box below to let us know you are a "real human being" and not a spambot. You must check this box for your posting to be submitted: I am a real person and not a spambot The following information is optional. your name:

your organization:
Check the box below if you wish Angioplasty.Org to "anonymize" your posting (for example, John Doe, Baltimore, Maryland, USA would become John D., Maryland, USA): please anonymize me To submit your post, please click the button below once and wait for a confirmation.
Clicking more than once will result in multiple submissions.